Mumbai, 21st January 2025: Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a premier player in the global pharmaceutical industry, has announced the successful renewal of its European Good Manufacturing Practices (EU-GMP) certification by Infarmed, the National Authority of Medicines and Health Products in Portugal. This renewal, applicable to the company’s state-of-the-art manufacturing facility for Cephalosporin, […]
The post Venus Remedies Secures Eu Gmp Renewal From Infarmed, Strengthens European Market Presence first appeared on Business News Week.